India Malaria Vaccine Market to be Supported by Increasing research and development (R&D) activities through 2028.
Increasing
Investment in Biotechnology is expected to drive the India malaria vaccine
market in the forecast period, 2024-2028.
According to TechSci Research report, “India Malaria Vaccine Market - Industry
Size, Share, Trends, Opportunity, and Forecast, 2018-2028”, the
India Malaria Vaccine Market is anticipated to grow at an impressive
rate in the forecast period, 2024-2028. This can be ascribed to the rising number of clinical trials along with the increasing
investments and support from the government. Also, Indian vaccine manufacturers
are collaborating with global partners to develop and manufacture malaria
vaccines. For example, the Serum Institute of India has partnered with
Codagenix, a US-based biotech company, to develop an intranasal malaria vaccine.
Furthermore, the Indian government has implemented several policies to support
the growth of the biotechnology sector, including streamlined regulatory
processes for the development and approval of new vaccines. This has created a
favorable environment for vaccine manufacturers, including those working on
malaria vaccines, thus, in turn is expected to bolster the growth of the market
in the coming five years.
However, the cost of developing and manufacturing a malaria vaccine is
high, which is expected to hamper the growth of the India malaria vaccine market.
Besides, the government procurement process in India can be complex and
bureaucratic, which may slow down the growth of the India malaria vaccine
market.
Browse over XX market data
Figures spread through XX
Pages and an in-depth TOC on "India Malaria Vaccine Market”
India
Malaria Vaccine Market is segmented into vaccine type, roue of administration
and company.
Based
on vaccine type, India malaria vaccine market can be divided into
pre-erythrocytic, erythrocytic, multi-antigen, and others. Pre-Erythrocytic
segment is expected to dominate the India Malaria Vaccine Market due to its
high efficacy rates in clinical trials.
Based
on route of administration, the India malaria vaccine market is divided into
intramuscular, subcutaneous, intradermal, and others. The intramuscular segment
is expected to dominate the India Malaria Vaccine Market due to its rapid and
uniform absorption, rapid onset of the action, and others.
Major companies operating in India Malaria
Vaccine Market are:
- Gennova
Biopharmaceuticals Ltd
- Zydus Group
- Serum
Institute of India Private Limited
- Bharat
Biotech International Limited
- Indian
Immunologicals Limited
- Panacea Biotec
- Mynvax
- Cadila
Pharmaceuticals
- Biological E
Limited
- Sanofi
Pasteur
Download Free Sample Report
Customers can also request
for 10% free customization on this report.
“North India region is expected to dominate the India Malaria Vaccine Market
in the forecast period. This is attributed to a growing technological
advancement in the region. Besides, presence
of several research institutions, pharmaceutical companies, and non-profit
organizations in North India that are actively involved in developing and
testing malaria vaccines are one of the contributing factors for the growth of
the market in the region. Also, the partnerships between public and private
sectors along with the increasing number of clinical trials bode well for the
growth of India Malaria Vaccine Market” said Mr. Karan Chechi, Research
Director with TechSci Research, a research based global management consulting
firm.
“India
Malaria Vaccine Market, By Vaccine Type (Pre-Erythrocytic, Erythrocytic,
Multi-antigen, Others), By Route of Administration (Intramuscular, Subcutaneous,
Intradermal, Others), By Region, Competition, Forecast & Opportunities,
2028”, has evaluated the future growth potential of India
Malaria Vaccine Market and provides statistics & information on
market size, structure, and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in India
Malaria Vaccine Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Web: https://www.techsciresearch.com